Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers
Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page
- Check2 days agoNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record details. The header and footer remain, but the main content is inaccessible due to the error.SummaryDifference21%

- Check36 days agoChange DetectedRevision tag on the page was updated from v3.6.5 to v3.6.6, indicating a new page version. The change does not modify study details or content visible to users.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version is in effect. This change does not modify the displayed study data or user-facing functionality.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, indicating a new version of the page. This update does not specify any visible content changes.SummaryDifference0.0%

- Check93 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, representing a new version of the page. This appears to be an internal update or patch rather than a modification to the study content.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision: v3.6.2 replaces the previous Revision: v3.6.0 on the page, indicating a version update of the display template.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.